Biotechnology

• 10/22/2024

  Vertex Pharmaceuticals: Navigating a Turbulent Road to Success

• 10/21/2024

  Benitec Biopharma’s OPMD Breakthrough: Key Catalysts Ahead

• 10/20/2024

  Navigating AI’s Uncertain Future: Cash Burn and Clinical Hurdles

• 10/19/2024

  Hansa Biopharma 2024 Q3 Earnings: Results and Presentation Highlights

• 10/19/2024

  Hansa Biopharma Q3 2024 Earnings Call Transcript

• 10/9/2024

  **Reassessing Xeris Biopharma**

• 10/8/2024

  **BB-301: Potential in OPMD, But Still in Early Stages**

• 10/8/2024

  **Dianthus: A Modest Investment Opportunity**

• 10/8/2024

  **Anavex Stock: Risky CNS Drug Development Bet Downgraded**

• 10/7/2024

  **ImmunityBio: Driving Progress**